Overview
Physicians in the licensed Regenexx network offer advanced interventional orthopedic procedures as an alternative to common orthopedic surgeries. The Regenexx Corporate Program helps employers provide their employees with this high-quality, high-value option in care that can reduce the cost of individual surgeries by up to 70%.
Interventional Orthopedics
Interventional orthopedics is a medical specialty focused on non-surgical treatments for orthopedic conditions. It uses precise imaging to guide injections made from the patient’s own blood or bone marrow—known as interventional orthobiologics—to treat musculoskeletal pain and injury.
Procedures using Regenexx proprietary methods help harness the body’s natural healing ability to help repair damage to bones, muscles, cartilage, tendons, and ligaments. Additionally, this approach reduces use of medications or prescriptions and helps patients avoid steroids, which can have long-term side effects.
Using precisely guided injections of the patient’s own cells, the Regenexx approach is less invasive and may reduce the need for up to 70% of elective orthopedic surgeries.
Regenexx Orthobiologics
Regenexx injectates, produced using Regenexx lab processing, routinely achieve 20x concentration — far above what non-Regenexx providers achieve. The cell processing for Regenexx injectates requires an on-site laboratory and complies with US state and Federal law.
Regenexx SD injectate: marrow concentrate that contains stem cells, commonly referred to as stem cell therapy
Regenexx SCP injectate: A proprietary formulation of platelet-rich plasma (PRP)
Regenexx PL injectate: Platelet lysate, which is a highly specialized derivative of platelet-rich plasma (PRP)
Regenexx Orthobiologics
Regenexx injectates, produced using Regenexx lab processing, routinely achieve 20x concentration — far above what non-Regenexx providers achieve. The cell processing for Regenexx injectates requires an on-site laboratory and complies with US state and Federal law.
Common Conditions Treated
Physicians in the licensed Regenexx network specialize in treating a wide range of musculoskeletal conditions, helping patients achieve an improved quality of life and optimized functional status. Click a red dot in the graphic below for area specifics.
Download this booklet to explore an expanded list of conditions treated across all body areas.
The Regenexx Approach vs. Total Knee Replacement for Knee OA
A healthcare innovation research institute that conducted the first health technology assessment of its kind evaluating cost-effectiveness and quality of life (QoL). This independent economic analysis from UMC Utrecht's THINC compares outcomes for patients who were treated using bone marrow concentrate vs. total knee replacement focusing on working age adults.
The THINC report found that compared with TKR surgery for knee OA, procedures using Regenexx injectates demonstrated:
- ~$20k in cost savings over 5 years
- Comparable quality of life
- ~70% decrease in subsequent knee replacements
Download Knee OA Report
THINC Report Conclusion: The Regenexx approach offers a significantly cost-effective option with comparable QoL* for knee OA treatment.
*QALY = Cost-effectiveness analysis metric rating how well different types of medical treatments extend and/or improve patients’ lives.
